QN-302

· Qualigen Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QN-302, covering 2024-05-01 to 2024-05-01. Get the full timeline:

Most recent: Clinical Trial Update: Trial to Evaluate Safety, PD & PK of IV Study Drug, QN-302, in Pts w/ Advanced or Metastatic Solid Tumors [Phase 1]

See pricing